BioSpace News Archive

Eiger BioPharmaceuticals, Inc Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced the receipt of written guidance from the FDA, confirming concurrence on a pivotal trial design, including the primary endpoint for D-LIVR, the first-ever, registration study for Hepatitis Delta Virus (HDV) infection.

Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the presentation of new clinical and preclinical data for its investigational therapeutic candidates avapritinib, BLU-667 and BLU-782.

Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the company will participate in two investor conferences in October.

William Lautman, Managing Partner of Nexus Health Capital, a New York and Dallas-based Healthcare Investment Bank, today announced a one million dollar planned gift in addition to five hundred thousand dollars donated to Smile Train in order to bring forever smiles to children with clefts in Argentina and around the world.

Clubs in Chicago, Delaware and South Dakota win Back2School ‘Stuff the Bus’ Challenge from Boys & Girls Clubs of America, receiving Toyota Sienna minivans, cash and supplies worth more than $75,000

Spectrum Science Communications, a leading independent health and science public relations agency, has been named PR News’ 2018 Medium PR Firm of the Year.

Oral presentation to include new data from ASPIRO out to 48-weeks of follow-up in the earliest treated patients in dose Cohort 1, and preliminary safety and efficacy data from the sentinel patient in dose Cohort 2

Pharmaceutical companies share significant concerns over their ability to bring more drugs to market faster due to clinical data challenge

coflex® is the only posterior lumbar motion preservation solution with proven long-term outcomes for durable pain relief and stability for patients with moderate to severe spinal stenosis

Expands the Company’s global patent estate for the capture and detection of rare cells of interest, including CTCs shed by solid tumors, in blood and other biofluids